RLMD
Relmada Therapeutics Inc

1,931
Mkt Cap
$324.13M
Volume
1.65M
52W High
$5.12
52W Low
$0.2404
PE Ratio
-2.46
RLMD Fundamentals
Price
$4.31
Prev Close
$4.42
Open
$4.50
50D MA
$3.06
Beta
0.54
Avg. Volume
2.28M
EPS (Annual)
-$2.65
P/B
15.50
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Relmada Therapeutics (NASDAQ:RLMD) Announces Earnings Results
Relmada Therapeutics (NASDAQ:RLMD - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of...
MarketBeat·27d ago
News Placeholder
More News
News Placeholder
A Glimpse of Relmada Therapeutics's Earnings Potential
read more...
Benzinga·29d ago
News Placeholder
Insider Buying: Relmada Therapeutics (NASDAQ:RLMD) CFO Buys 500,000 Shares of Stock
Relmada Therapeutics, Inc. (NASDAQ:RLMD - Get Free Report) CFO Maged Shenouda acquired 500,000 shares of the business's stock in a transaction that occurred on Wednesday, November 5th. The shares...
MarketBeat·1mo ago
News Placeholder
Relmada Therapeutics (NASDAQ:RLMD) COO Buys $299,200.00 in Stock
Relmada Therapeutics, Inc. (NASDAQ:RLMD - Get Free Report) COO Chuck Ence bought 136,000 shares of Relmada Therapeutics stock in a transaction dated Wednesday, November 5th. The stock was purchased...
MarketBeat·1mo ago
News Placeholder
Relmada Therapeutics (NASDAQ:RLMD) COO Buys $198,000.00 in Stock
Relmada Therapeutics, Inc. (NASDAQ:RLMD - Get Free Report) COO Paul Edward Kelly bought 90,000 shares of the stock in a transaction on Wednesday, November 5th. The stock was purchased at an average...
MarketBeat·1mo ago
News Placeholder
Insider Buying: Relmada Therapeutics (NASDAQ:RLMD) COO Purchases 90,000 Shares of Stock
Relmada Therapeutics, Inc. (NASDAQ:RLMD - Get Free Report) COO Paul Edward Kelly bought 90,000 shares of Relmada Therapeutics stock in a transaction that occurred on Wednesday, November 5th. The...
MarketBeat·1mo ago

Latest RLMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.